Noelle V. Frey - Concepedia

Author

Noelle V. Frey

University of Pennsylvania ORCID

Also Known As

N FREY, N Frey, N V Frey, N. Frey, N. V. Frey, N.V. Frey, Natalie Stefano, Noelle Frey, Noelle V Frey, Noelle V. Frey

451

Publications

22.7K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Children's Hospital of Philadelphia Hospital of the University of Pennsylvania Novartis (United States)Parker Institute for Cancer Immunotherapy

About

Noelle V. Frey is an author at University of Pennsylvania specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	37	4.7K
2	Cell Biology	7	7	3K
3	Health Sciences	6	6	212
4	Allergy	5	5	718
5	Blood Transplantation	3	3	114

Noelle V. Frey

Publications

17K

Citations

H-Index

Page 1

	Year	Citations
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, New England Journal of Medicine	2014	5.3K
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia David Porter, Wei‐Ting Hwang, Noelle V. Frey, Science Translational Medicine	2015	1.7K
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando, Nature Medicine T Cell TherapyCancer ImmunosurveillanceChronic Lymphocytic LeukemiaHematologyImmunology	2018	1.7K
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia David T. Teachey, Simon F. Lacey, Pamela A. Shaw, Cancer Discovery	2016	1.1K
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells J. Joseph Melenhorst, Gregory M. Chen, Meng Wang, Nature Hematological MalignancyDecade-long Leukaemia RemissionsMalignant Blood DisorderT-regulatory CellImmunology	2022	851
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia Julie C. Fitzgerald, Scott L. Weiss, Shannon L. Maude, Critical Care Medicine	2016	444
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia Karen Thudium Mueller, Shannon L. Maude, David L. Porter, Blood	2017	348
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction Nathan Singh, Yong Gu Lee, Olga Shestova, Cancer Discovery	2020	288
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy Melody Smith, Anqi Dai, Guido Ghilardi, Nature Medicine DysbiosisAllergyGut Microbiome CorrelatesMucosal ImmunologyT-regulatory Cell	2022	285
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Melissa Hines, Tristan Knight, Kevin O. McNerney, Transplantation and Cellular Therapy	2023	264

Page 1